NCT01642251 2023-05-06Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1/2 Completed156 enrolled 13 charts
NCT00537511 2019-11-19A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and EtoposideCelgenePhase 1/2 Terminated22 enrolled 13 charts